{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:17Z","timestamp":1794002837187,"version":"4.8.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41409-024-02316-0","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T08:02:04Z","timestamp":1716624124000},"page":"1232-1238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Donor\/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens"],"prefix":"10.1038","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4449-989X","authenticated-orcid":false,"given":"Ali\u00e9nor","family":"Xhaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Floch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Ruggiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-9876","authenticated-orcid":false,"given":"Marie","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-1556","authenticated-orcid":false,"given":"Flore","family":"Sicre de Fontbrune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4553-3065","authenticated-orcid":false,"given":"David","family":"Michonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonore","family":"Kaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-7890","authenticated-orcid":false,"given":"Pedro Henrique de Lima","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-7533","authenticated-orcid":false,"given":"G\u00e9rard","family":"Soci\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Traineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lepr\u00eatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"2316_CR1","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/bmt.2011.135","volume":"46","author":"SD Rowley","year":"2011","unstructured":"Rowley SD, Donato ML, Bhattacharyya P. Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2011;46:1167\u201385.","journal-title":"Bone Marrow Transplant"},{"key":"2316_CR2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1182\/asheducation-2015.1.378","volume":"2015","author":"A Holbro","year":"2015","unstructured":"Holbro A, Passweg JR. Management of hemolytic anemia following allogeneic stem cell transplantation. Hematol Am Soc Hematol Educ Progr. 2015;2015:378\u201384.","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"2316_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3329\/bjms.v18i4.42911","volume":"18","author":"R Yousuf","year":"2019","unstructured":"Yousuf R, Thalith NFA, Loong TY, Leong CF. Naturally occurring \u2018enzyme only\u2019 anti-E antibody: a rare occurrence. Bangladesh J Med Sci. 2019;18:818\u20139.","journal-title":"Bangladesh J Med Sci"},{"key":"2316_CR4","first-page":"123","volume":"19","author":"J Harrison","year":"1970","unstructured":"Harrison J. The \u2018naturally occurring\u2019 anti\u2010E. Vox Sang. 1970;19:123\u201331.","journal-title":"Vox Sang"},{"key":"2316_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/sj.bmt.1703074","volume":"27","author":"PP Young","year":"2001","unstructured":"Young PP, Goodnough LT, Westervelt P, Diersio JF. Immune hemolysis involving non-ABO\/RhD alloantibodies following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:1305\u201310.","journal-title":"Bone Marrow Transplant"},{"key":"2316_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/sj.bmt.1704524","volume":"33","author":"M Franchini","year":"2004","unstructured":"Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:1169\u201372.","journal-title":"Bone Marrow Transplant"},{"key":"2316_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.bbmt.2010.03.021","volume":"16","author":"N Blin","year":"2010","unstructured":"Blin N, Traineau R, Houssin S, Peffault de Latour R, Petropoulou A, Robin M, et al. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source. Biol Blood Marrow Transplant. 2010;16:1315\u201323.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2316_CR8","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.bulcan.2018.08.016","volume":"106","author":"C Giraud","year":"2019","unstructured":"Giraud C, Thibert JB, Desbrosses Y, Debiol B, Alsuliman T, Bardiaux L, et al. Transfusion dans l\u2019autogreffe et l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez l\u2019adulte et l\u2019enfant: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC). Bull du Cancer. 2019;106:S52\u20138.","journal-title":"Bull du Cancer"},{"key":"2316_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/j.1537-2995.2011.03457.x","volume":"52","author":"N Worel","year":"2012","unstructured":"Worel N, B\u00f6hm A, Rabitsch W, Leitner G, Mitterbauer M, Kalhs P, et al. Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning. Transfusion. 2012;52:1348\u201353.","journal-title":"Transfusion"},{"key":"2316_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/bmt.2012.152","volume":"48","author":"JYS Chan","year":"2013","unstructured":"Chan JYS, Tokessy M, Saidenberg E, Giulivi A, Tay J, Allan DS. Rh D alloimmunization in allogeneic HSCT. Bone Marrow Transplant. 2013;48:459\u201360.","journal-title":"Bone Marrow Transplant"},{"key":"2316_CR11","doi-asserted-by":"crossref","unstructured":"Xhaard A, Bouton M, Delugin L, Giraud C, Guyon A, Giroux-Lathuile C, et al. [Transfusion management and immuno-hematological follow-up after allogeneic hematopoietic cell transplantation: recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull du Cancer. 2024;11;S78\u201383.","DOI":"10.1016\/j.bulcan.2023.03.004"},{"key":"2316_CR12","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1111\/trf.14232","volume":"57","author":"R Bail\u00e9n","year":"2017","unstructured":"Bail\u00e9n R, Kwon M, P\u00e9rez-Corral AM, Pascual C, Bu\u00f1o I, Balsalobre P, et al. Transient hemolysis due to anti-D and anti-A1 produced by engrafted donor\u2019s lymphocytes after allogeneic unmanipulated haploidentical hematopoietic stem cell transplantation. Transfusion. 2017;57:2355\u20138.","journal-title":"Transfusion"},{"key":"2316_CR13","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2316_CR14","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2316_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389\u2013401.e1.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2316_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/vox.12455","volume":"112","author":"Y Lin","year":"2017","unstructured":"Lin Y, Saskin A, Wells RA, Lenis M, Mamedov A, Callum J, et al. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes. Vox Sang. 2017;112:79\u201386.","journal-title":"Vox Sang"},{"key":"2316_CR17","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0145-2126(99)00113-7","volume":"23","author":"P Gupta","year":"1999","unstructured":"Gupta P, LeRoy SC, Luikart SD, Bateman A, Morrison VA. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications. Leuk Res. 1999;23:953\u20139.","journal-title":"Leuk Res"},{"key":"2316_CR18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1537-2995.2012.03819.x","volume":"53","author":"C Sanz","year":"2013","unstructured":"Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion. 2013;53:710\u20135.","journal-title":"Transfusion"},{"key":"2316_CR19","first-page":"472","volume":"15","author":"S Ortiz","year":"2017","unstructured":"Ortiz S, Orero MT, Javier K, Villegas C, Luna I, P\u00e9rez P, et al. Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome. Blood Transfus. 2017;15:472\u20137.","journal-title":"Blood Transfus"},{"key":"2316_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1046\/j.1537-2995.1999.39070763.x","volume":"39","author":"H Schonewille","year":"1999","unstructured":"Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39:763\u201371.","journal-title":"Transfusion"},{"key":"2316_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/vox.13237","volume":"117","author":"A Xhaard","year":"2022","unstructured":"Xhaard A, Miekoutima E, Pirenne F, Fran\u00e7ois A, Tiberghien P, Sebert M, et al. The transfusion of non-prophylactically RH-KEL1 antigen-matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients. Vox Sang. 2022;117:693\u2013700.","journal-title":"Vox Sang"},{"key":"2316_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1046\/j.1365-2141.2002.03268.x","volume":"116","author":"M Mielcarek","year":"2002","unstructured":"Mielcarek M, Zaucha JM, Sandmaier B, Maloney D, Butrynski J, Maris M, et al. Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility. Br J Haematol. 2002;116:500\u20131.","journal-title":"Br J Haematol"},{"key":"2316_CR23","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","volume":"105","author":"DB Miklos","year":"2005","unstructured":"Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005;105:2973\u20138.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02316-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T09:07:56Z","timestamp":1725268076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02316-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2316"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02316-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3972452\/v1","asserted-by":"object"}]},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects (Comit\u00e9 d\u2019Evaluation Ethique de l\u2019Inserm CEEI\/IRB du 13 avril 2021, avis 21-799).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}